نتایج جستجو برای: fgfr2 gene

تعداد نتایج: 1142053  

2017
Sun Young Kim Taejin Ahn Heejin Bang Jun Soo Ham Jusun Kim Seung Tae Kim Jiryeon Jang Moonhee Shim So Young Kang Se Hoon Park Byung Hoon Min Hyuk Lee Won Ki Kang Kyoung-Mee Kim Woongyang Park Jeeyun Lee

BACKGROUND Fibroblast growth factor 2 (FGFR2) amplification, occurring in ~2-9% of gastric cancers (GC), is associated with poor overall survival. RESULTS RNA sequencing identified a novel FGFR2-ACSL5 fusion in the resistant tumor that was absent from the matched pre-treatment tumor. The FGFR2-amplified PDC line was sensitive to FGFR inhibitors whereas the PDC line with concomitant FGFR2 ampl...

Journal: :Journal of cellular physiology 2007
Allison B Moffa Stephen P Ethier

Gene amplification and protein overexpression of fibroblast growth factor receptor 2 (FGFR2) characterize the SUM-52 breast cancer cell line developed in our laboratory. SUM-52 cells express nine distinct alternatively spliced isoforms of FGFR2. Among these isoforms are two otherwise identical FGFR2 variants that express either the C1 or C3 carboxyl terminus. FGFR2-C3 variants are not normally ...

Journal: :The Journal of Biological Chemistry 2009
Fenyong Sun Qiuling Xie Ji Ma Songhai Yang Qiongyu Chen An Hong

Fibroblast growth factor receptor 2 (FGFR2) plays an important regulatory role in bone development. However, the regulatory mechanisms controlling FGFR2 expression remain poorly understood. Here we have identified a role for the nuclear factor Y (NF-Y) in constitutive activation of FGFR2. A unique DNase I hypersensitive site was detected in the region encompassing nucleotides -270 to +230 after...

2013
Erika Yeh Roberto D. Fanganiello Daniele Y. Sunaga Xueyan Zhou Gregory Holmes Katia M. Rocha Nivaldo Alonso Hamilton Matushita Yingli Wang Ethylin W. Jabs Maria Rita Passos-Bueno

Apert syndrome (AS), the most severe form craniosynostosis, is characterized by premature fusion of coronal sutures. Approximately 70% of AS patients carry S252W gain-of-function mutation in FGFR2. Besides the cranial phenotype, brain dysmorphologies are present and are not seen in other FGFR2-asociated craniosynostosis, such as Crouzon syndrome (CS). Here, we hypothesized that S252W mutation l...

2016
Rahem Khoshbakht Mohammad Tabatabaei Saeid Hoseinzadeh Mojtaba Mojtaba Hesamaddin Shirzad Aski Enayat Berizi

The receptors 1 and 2 of fibroblast growth factor (FGFR1 and FGFR2, respectively) have been observed in all types of testicular cells. Culture on extracellular matrix (ECM) has been observed to lead to initiation of differentiation in spermatogonial stem cells (SSCs). The present study was carried out to investigate whether FGFR1 and FGFR2 play a role in SSCs differentiation. Following isolatio...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1999
E Arman R Haffner-Krausz M Gorivodsky P Lonai

The aim of this study was to clarify the role of Fgfr2 during later stages of embryonic development. Of two previously reported gene-targeting experiments, the more extensive Fgfr2 deletion was lethal shortly after implantation, because of trophoblast defects, whereas the less extensive one survived until midgestation with placental insufficiency and defective limb outgrowth [Xu, X., Weinstein,...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2008
Amit Dutt Helga B Salvesen Tzu-Hsiu Chen Alex H Ramos Robert C Onofrio Charlie Hatton Richard Nicoletti Wendy Winckler Rupinder Grewal Megan Hanna Nicolas Wyhs Liuda Ziaugra Daniel J Richter Jone Trovik Ingeborg B Engelsen Ingunn M Stefansson Tim Fennell Kristian Cibulskis Michael C Zody Lars A Akslen Stacey Gabriel Kwok-Kin Wong William R Sellers Matthew Meyerson Heidi Greulich

Oncogenic activation of tyrosine kinases is a common mechanism of carcinogenesis and, given the druggable nature of these enzymes, an attractive target for anticancer therapy. Here, we show that somatic mutations of the fibroblast growth factor receptor 2 (FGFR2) tyrosine kinase gene, FGFR2, are present in 12% of endometrial carcinomas, with additional instances found in lung squamous cell carc...

2014
Anjili Mathur Christopher Ware Lenora Davis Adi Gazdar Bo-Sheng Pan Bart Lutterbach

Aberrant kinase activation resulting from mutation, amplification, or translocation can drive growth and survival in a subset of human cancer. FGFR2 is amplified in breast and gastric cancer, and we report here the first characterization of FGFR2 gene amplification in colorectal cancer in the NCI-H716 colorectal cancer cell line. FGFR2 is highly expressed and activated in NCI-H716 cells, and FG...

2013
Liang Xie Lin Zhang Xiaolu Yin Lili Tang Xiuhua Zhang Yanping Xu Kunji Liu Minhua Zhou Beirong Gao Danping Shen Lianhai Zhang Jiafu Ji Paul R. Gavine Jingchuan Zhang Elaine Kilgour Xiaolin Zhang Qunsheng Ji

Purpose: FGFR gene aberrations are associated with tumor growth and survival. We explored the role of FGFR2 amplification in gastric cancer and the therapeutic potential of AZD4547, a potent and selective ATPcompetitive receptor tyrosine kinase inhibitor of fibroblast growth factor receptor (FGFR)1–3, in patients with FGFR2-amplified gastric cancer. Experimental Design: Array-comparative genomi...

2013
Nadine Reintjes Yun Li Alexandra Becker Edyta Rohmann Rita Schmutzler Bernd Wollnik

It is known that FGFR2 gene variations confer a risk for breast cancer. FGFR2 and FGF10, the main ligand of FGFR2, are both overexpressed in 5-10% of breast tumors. In our study, we sequenced the most important coding regions of FGFR2 in somatic tumor tissue of 140 sporadic breast cancer patients and performed MLPA analysis to detect copy number variations in FGFR2 and FGF10. We identified one ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید